Finn K. Hansen @FKH_Lab

Professor of Pharmaceutical Chemistry at University of Bonn, Germany. Vice speaker of @GRK2873. pharma.uni-bonn.de/www/pharmchem2… Bonn, Deutschland Joined March 2018

Tweets

578
Followers

608
Following

406
Likes

1K

Finn K. Hansen @FKH_Lab

2 weeks ago

Happy to share our publication dealing with the targeted #HDAC degradation via direct DDB1 recruitment. Congrats to first author Shiyang @Vincent_SYZ and everybody involved. Great collaboration with the Geyer lab @Geyer_lab! #BonnTPD pubs.acs.org/doi/10.1021/ac…

2 1 8 403 1

Finn K. Hansen @FKH_Lab

2 months ago

Happy to share the latest publication from my lab: we developed a NanoBRET based target engagement assay for HDAC6. Furthermore this system allows to track the HDAC6 degradation by PROTACs in real-time. Congrats to my postdoc Maria and everybody involved.pubs.acs.org/doi/10.1021/ac…

1 2 22 632 2

Guillaume Laconde @Glaconde34

2 months ago

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability | Journal of Medicinal Chemistry pubs.acs.org/doi/10.1021/ac…

2 4 18 1K 2

Finn K. Hansen @FKH_Lab

3 months ago

The University of Bonn offers two PhD scholarship financed by the DAAD within the DAAD-GSSP Programme. The PhD students will be associated to the Research Training Group RTG/GRK 2873 @grk2873 Apply now! Please RT. grk2873.uni-bonn.de/en/training-pr…

0 3 6 1K 2

Finn K. Hansen @FKH_Lab

3 months ago

Happy to see our dual HDAC6/10 #PROTAC paper out in #JMedChem. I am extremely proud of my PhD student Shiyang @Vincent_SYZ for making this possible. Huge thanks to all collaborators and co-workers for their amazing contributions! pubs.acs.org/doi/10.1021/ac…

1 1 18 500 0

Alessio Ciulli @alessiociulli

6 months ago

Thrilled to see Our FerroTac story is now out at @J_A_C_S - Huge congrats 🙌🏻 🥳 @ales_salerno Lianne and Claudia! @UoDCeTPD

J. Am. Chem. Soc. @J_A_C_S

6 months ago

Thrilled to see Our FerroTac story is now out at @J_A_C_S - Huge congrats 🙌🏻 🥳 @ales_salerno Lianne and Claudia! @UoDCeTPD

0 17 104 11K 21

2 5 42 4K 1

Chemistry Europe @ChemEurope

6 months ago

#ChemMedChem Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan-Degrader (Finn K. Hansen and co-workers) #openaccess 🔓 onlinelibrary.wiley.com/doi/10.1002/cm…

0 3 8 850 1

Finn K. Hansen @FKH_Lab

6 months ago

Happy to share the final version of our DCAF11-recruiting #HDAC #PROTAC paper. Congrats to my co-workers Felix @fellerflix, Heiko, Martina, Irina and Maria! …mistry-europe.onlinelibrary.wiley.com/doi/10.1002/cm…

0 3 18 691 3

Finn K. Hansen @FKH_Lab

7 months ago

The next chapter of our HDAC #PROTAC story: CRBN-recruiting PROTACs based on a non-selective ethylhydrazide #HDAC warhead induce selective HDAC6 degradation. Congrats to my PhD students Daniel @danicious & Irina (co-first authors), and Felix @fellerflix. pubs.acs.org/doi/full/10.10…

0 4 18 1K 3

Finn K. Hansen @FKH_Lab

8 months ago

Thrilled to share our #JMedChem paper dealing with DS-103! The ethylhydrazide DS-103 fully reverses cisplatin resistance and binds to HDAC6 in a manner similar to a hydroxamate. Huge congrats to first authors Daniel @danicious & Lukas and the entire team! pubs.acs.org/doi/10.1021/ac…

0 3 19 2K 2

Finn K. Hansen @FKH_Lab

8 months ago

Happy to share our latest paper in #JMedChem on improved antagonists targeting the intracellular allosteric binding site of CCR7! Huge thanks and congratulations to the whole team for the incredible teamwork! pubs.acs.org/doi/10.1021/ac…

0 3 15 675 0

Finn K. Hansen @FKH_Lab

8 months ago

Excited to share our latest publication on #HDAC inhibitor-based multineurotarget drugs as a potential treatment option for Alzheimer´s disease, now online in ACS Pharmacology & TS! 🎉 Huge congrats to our amazing team and collaborators! pubs.acs.org/doi/full/10.10…

1 3 35 2K 3

Finn K. Hansen @FKH_Lab

9 months ago

New #PROTAC preprint: In this work, we utilized a non-selective ethyl hydrazide warhead for the selective HDAC6 degradation. Congratulations to co-first authors Daniel @danicious & Irina as well as Felix @fellerflix ! go.shr.lc/4jinjC0

0 2 20 955 0

Finn K. Hansen @FKH_Lab

9 months ago

Kicking of the new year with our first publication: Our paper dealing with FEM1B-recruiting HDAC #PROTACs is online in #JMedChem @ACSBioMed. We noticed selective HDAC1-3 degradation. Congrats to Felix @fellerflix, Irina, Martina, Heiko, Svenja and Maria! pubs.acs.org/doi/10.1021/ac…

2 7 41 3K 2

Finn K. Hansen @FKH_Lab

9 months ago

The application period for the second cohort of our RTG 2873 @grk2873 is open! We are now recruiting 12 PhD students. For more information see our homepage: grk2873.uni-bonn.de/en. My own project will focus on the development of HDAC #PROTACs. Please RT! grk2873.uni-bonn.de/en/training-pr…

0 2 8 598 0

Finn K. Hansen @FKH_Lab

9 months ago

Let´s continue our E3 ligase hopping party! Second stop: DCAF11. The switch from a CRBN to a DCAF11 recruiter converts a selective HDAC6 PROTAC into a pan-degrader. Congrats to first author Felix @fellerflix and my coworkers Heiko, Martina, Irina & Maria! go.shr.lc/3C1jgcA

0 3 19 633 0

Finn K. Hansen @FKH_Lab

10 months ago

Check out our latest preprint on #PHOTACs: Light-activatable PHOTACs enable the optical control of targeted HDAC6 degradation. Huge congrats to Silas @WurnigSilas , Maria, Shiyang @Vincent_SYZ , and our amazing collaborators in the Nowak lab @RPNowak ! go.shr.lc/3ZudhVq

0 2 17 831 0

Finn K. Hansen @FKH_Lab

11 months ago

Happy to announce that our paper on the multicomponent synthesis of quisinostat analogs as anticancer and antiplasmodial #HDAC inhibitors has been published. Congratulations to first author Daniel @danicious and all co-workers and collaborators involved! sciencedirect.com/science/articl…

0 0 19 1K 0

Bahaa Elgendy بهاء الجندي @ElgendyBE

11 months ago

I stood in line for 3 hours to vote today! 🇺🇸 It’s a small price to pay for democracy and our right to have a voice. Voting is more than a duty; it’s a privilege. Let’s participate, make our voices heard, and respect the outcome, whatever it may be.